Medivolve Inc
OTC:MEDVF

Watchlist Manager
Medivolve Inc Logo
Medivolve Inc
OTC:MEDVF
Watchlist
Price: 0.006 USD 20% Market Closed
Market Cap: 19.6m USD
Have any thoughts about
Medivolve Inc?
Write Note

Medivolve Inc
Investor Relations

Medivolve, Inc. engages in seeking technologies, ground-breaking innovations, and exclusive partnerships to help combat COVID-19 and generate risk-adjusted returns for investors. The company is headquartered in Toronto, Ontario. The company went IPO on 2009-11-16. The firm is engaged in providing telehealth platform, a clinical diagnostic network, and a data driven artificial intelligence (AI) framework to improve patient care. The company offers a network of retail collection sites, which provides clinical services in diagnostic testing, vaccinations, and other point-of-care services. The company is also engaged in developing technologies to identify, treat, and prevent medical issues. The company provides solution in COVID-19 testing, immunity scoring, and vaccinations. Its COVID-19 Testing includes rapid antibody blood test, reverse transcription (RT)- polymerase chain reaction (PCR) test and antigen test. The firm uses channel partner Aditxt Therapeutics, Inc. (Aditxt) to offer COVID-19 immunity status monitoring through its mobile testing centers.

Show more

Earnings Calls

No Earnings Calls Available

Management

Mr. Neil Said
General Counsel
No Bio Available
Mr. Indivar Pathak
Chief Operating Officer - Collection Sites
No Bio Available
Pamela Kennedy
Sr. Advisor Government Affairs
No Bio Available
Mr. David Preiner
Consultant
No Bio Available
Dominique Vaillancourt
Manager of Investor Relations
No Bio Available

Contacts

Address
ONTARIO
TORONTO
65 Queen St W Suite 800
Contacts
+14168615888.0
medevolve.com